/Companies

Deverra Therapeutics

Seattle, US · Founded 2019 · Delaware corporation

Find your way into Deverra Therapeutics

Sign up to see every warm intro you have to Deverra Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Deverra Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CD
Colleen DelaneyNamed on SEC filing
MW
Michael W YurkowskyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 2 rounds · 2020–2023

▶$2.4MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael YurkowskyExecutive Officer
  • Colleen DelaneyExecutive Officer
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$2.4M
Sales commissions
$80K
Placement agents
RBC Capital Markets
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b, 3C, 3C.1
Full filing on SEC EDGAR ↗
▶$75KraisedAug 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Colleen DelaneyExecutive Officer
  • Michael W YurkowskyExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$75K
Minimum investment
$25K
Sales commissions
$210K
Placement agents
Silverwood Partners, Silverwood Partners
First sale
Aug 2020
Incorporated
Corporation, Minnesota, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Deverra Therapeutics raised?
Deverra Therapeutics has disclosed $2.5M raised across 2 rounds.
Where is Deverra Therapeutics headquartered?
Deverra Therapeutics is headquartered in Seattle, US.